Nuclear Factor-κB: a Key Regulator in Health and Disease of Lungs

Overview

Journal Arch Immunol Ther Exp (Warsz)

Publisher Sciendo

Specialty Allergy & Immunology

Date 2011 Jul 26

PMID 21786215

Citations 30

Authors

Sanjay Batra

Gayathriy Balamayooran

Malaya K Sahoo

Affiliations

Soon will be listed here.

Abstract

Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.

Citing Articles

A Systematic Review of Gene Expression Studies in Critically Ill Patients with Sepsis and Community-Acquired Pneumonia.

Viasus D, Nonell L, Restrepo C, Figueroa F, Donado-Mazarron C, Carratala J Biomedicines. 2023; 11(10).

PMID: 37893128 PMC: 10604146. DOI: 10.3390/biomedicines11102755.

Extract Attenuates Airway Inflammation in a Mouse Model of Respiratory Disease Induced by Particulate Matter 10 Plus Diesel Exhaust Particles.

Sung Y, Kim M, Yuk H, Kim S, Yang W, Park G Nutrients. 2023; 15(19).

PMID: 37836429 PMC: 10574535. DOI: 10.3390/nu15194140.

Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer.

Wang X, Liu X, Yang Y, Yang D Bioengineered. 2022; 13(3):6866-6879.

PMID: 35246017 PMC: 8974107. DOI: 10.1080/21655979.2022.2043099.

Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling.

Windmoller B, Beshay M, Helweg L, Flottmann C, Beermann M, Forster C Cells. 2021; 10(5).

PMID: 33925297 PMC: 8145874. DOI: 10.3390/cells10051024.

A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2.

Kreis N, Ritter A, Louwen F, Yuan J Cells. 2020; 9(8).

PMID: 32722449 PMC: 7465902. DOI: 10.3390/cells9081777.

References

Ritter C, Andrades M, Frota Junior M, Bonatto F, Pinho R, Polydoro M . Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med. 2003; 29(10):1782-9. DOI: 10.1007/s00134-003-1789-9. View

Meylan E, Dooley A, Feldser D, Shen L, Turk E, OuYang C . Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature. 2009; 462(7269):104-7. PMC: 2780341. DOI: 10.1038/nature08462. View

Davies A, Ruel C, Lara P, Lau D, Gumerlock P, Bold R . The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study. J Thorac Oncol. 2008; 3(1):68-74. DOI: 10.1097/JTO.0b013e31815e8b88. View

Scagliotti G, Germonpre P, Bosquee L, Vansteenkiste J, Gervais R, Planchard D . A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. Lung Cancer. 2009; 68(3):420-6. DOI: 10.1016/j.lungcan.2009.07.011. View

Greten F, Eckmann L, Greten T, Park J, Li Z, Egan L . IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004; 118(3):285-96. DOI: 10.1016/j.cell.2004.07.013. View

Henneke I, Greschus S, Savai R, Korfei M, Markart P, Mahavadi P . Inhibition of urokinase activity reduces primary tumor growth and metastasis formation in a murine lung carcinoma model. Am J Respir Crit Care Med. 2010; 181(6):611-9. DOI: 10.1164/rccm.200903-0342OC. View

Turpin P, Rodriguez M, Thomas D, Hay R, Virelizier J, Dargemont C . Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci. 1997; 110 ( Pt 3):369-78. DOI: 10.1242/jcs.110.3.369. View

Isomura I, Morita A . Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides. Microbiol Immunol. 2006; 50(8):559-63. DOI: 10.1111/j.1348-0421.2006.tb03827.x. View

Iordanskiy S, Iordanskaya T, Quivy V, Van Lint C, Bukrinsky M . B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity. Virology. 2002; 302(1):195-206. DOI: 10.1006/viro.2002.1618. View

10.

Baeuerle P, Henkel T . Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994; 12:141-79. DOI: 10.1146/annurev.iy.12.040194.001041. View

11.

Voortman J, Checinska A, Giaccone G, Rodriguez J, Kruyt F . Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCI-H460. Mol Cancer Ther. 2007; 6(3):1046-53. DOI: 10.1158/1535-7163.MCT-06-0577. View

12.

Lancaster L, Christman J, Blackwell T, Koay M, Blackwell T . Suppression of lung inflammation in rats by prevention of NF-kappaB activation in the liver. Inflammation. 2001; 25(1):25-31. DOI: 10.1023/a:1007071527408. View

13.

Mortenson M, Schlieman M, Virudachalam S, Bold R . Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line. Cancer Chemother Pharmacol. 2004; 54(4):343-53. DOI: 10.1007/s00280-004-0811-4. View

14.

Yang X, Huang B, Li M, Lamb A, Kelleher N, Chen L . Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J. 2009; 28(8):1055-66. PMC: 2683704. DOI: 10.1038/emboj.2009.55. View

15.

Rothwarf D, Zandi E, Natoli G, Karin M . IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 1998; 395(6699):297-300. DOI: 10.1038/26261. View

16.

Giuliani C, Napolitano G, Bucci I, Montani V, Monaco F . [Nf-kB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications]. Clin Ter. 2001; 152(4):249-53. View

17.

Mizgerd J . Acute lower respiratory tract infection. N Engl J Med. 2008; 358(7):716-27. PMC: 2711392. DOI: 10.1056/NEJMra074111. View

18.

Hatada E, Nieters A, Wulczyn F, Naumann M, Meyer R, Nucifora G . The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc Natl Acad Sci U S A. 1992; 89(6):2489-93. PMC: 48684. DOI: 10.1073/pnas.89.6.2489. View

19.

Sadikot R, Zeng H, Yull F, Li B, Cheng D, Kernodle D . p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol. 2004; 172(3):1801-8. DOI: 10.4049/jimmunol.172.3.1801. View

20.

Saccani S, Pantano S, Natoli G . Modulation of NF-kappaB activity by exchange of dimers. Mol Cell. 2003; 11(6):1563-74. DOI: 10.1016/s1097-2765(03)00227-2. View